Genepoint Biological Technology
Shanghai
About Genepoint Biological Technology
Genepoint Biological Technology is an innovative technology that focuses on the initiatives, technology application, and process control of cryogenic biomaterials, which includes the generation of a cryogenic cell storage automation system and the total solution of alternative energy options. They are dedicated to advancing IoT, automation, and intelligence technology and investigating novel cryogenic biomaterial system operating paradigms. They provide the following products: Hatch TM, Pelican, Hatch-Lite, Flexible Robot for Biobank, and Kiosk.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $51.4M
- Funding stage: Late Stage Venture
- Last round: Series D (Jan 2023)
- Website: genepoint.cn
- Phone: +86 021-6422-9802
Industries & Categories
Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/genepoint-biological-technology-56537 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.